Electromedical Technologies

Electromedical Technologies FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Electromedical Technologies (EMED) as of Nov 2, 2026 is 10.37 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 8.69 % — a change of 19.30% (higher).

FCF Conversion

10.37 %

YoY

19.30%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Electromedical Technologies is 2025 10.37 % . FCF Conversion Rate (FCF/EBITDA) of Electromedical Technologies was 2024 8.69 % . It decreases by 19.30% higher compared to the previous year.

The Electromedical Technologies FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
18.43 USD
Jan 1, 2019
16.10 USD
Jan 1, 2020
34.52 USD
Jan 1, 2021
14.08 USD
Jan 1, 2022
22.30 USD
Jan 1, 2023
59.33 USD
Jan 1, 2024
8.69 USD
Jan 1, 2025
10.37 USD
The Electromedical Technologies FCF Conversion history
YEARFCF ConversionYoY
10.37 %+19.30%
8.69 %-85.35%
59.33 %+166.11%
22.30 %+58.39%
14.08 %-59.23%
34.52 %+114.48%
16.10 %-12.64%
18.43 %-31.81%
27.02 %-36.72%
42.70 %-72.65%
156.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Electromedical Technologies Stock analysis

What does Electromedical Technologies do? Electromedical Technologies, Inc. generates revenue through the sale of medical devices for pain management, specifically targeting consumers and healthcare professionals. The company's primary products include WellnessPro Plus, WellnessPro POD, and Wellness ION Pen, which utilize bioelectronics and electrical impulses to alleviate pain without drugs. WellnessPro Plus functions as a prescription device that mimics the body's electric signals with micro-current stimulation, while the Wellness ION Pen delivers targeted frequency stimulation via interferential cold laser technology. These products are designed for both consumer and professional use in chronic and acute pain relief. The company focuses on developing electronic medicine solutions that combine micro-stimulation with expanded wavelength capabilities, particularly through the Wellness ION Pen, which is intended for over-the-counter sales. WellnessPro POD is part of the product lineup but lacks detailed description in the business description. The target segments are consumers seeking non-drug pain relief and healthcare professionals who prescribe or recommend these devices for pain management. Electromedical Technologies, Inc. markets its products under the WellnessPro and Wellness ION Pen brand names, emphasizing their unique bioelectronics approach. The company's revenue streams are derived from direct sales of these devices, with WellnessPro Plus positioned as an intelligent therapy device for both home and clinical use. The Wellness ION Pen's over-the-counter availability expands its market reach to general consumers who prefer non-prescription pain management solutions. Electromedical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Electromedical Technologies stock

FCF Conversion Rate (FCF/EBITDA) of Electromedical Technologies is 10.37 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Electromedical Technologies changed from 8.69 % to 10.37 %, representing a 19.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Electromedical Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Electromedical Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Electromedical Technologies

All Key Metrics — Electromedical Technologies